Annual Shareholders Equity
$700.91 M
+$103.43 M+17.31%
December 31, 2023
Summary
- As of February 7, 2025, LGND annual stockholders equity is $700.91 million, with the most recent change of +$103.43 million (+17.31%) on December 31, 2023.
- During the last 3 years, LGND annual shareholders equity has fallen by -$8.61 million (-1.21%).
- LGND annual shareholders equity is now -14.64% below its all-time high of $821.16 million, reached on December 31, 2021.
Performance
LGND Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$841.18 M
+$65.98 M+8.51%
September 30, 2024
Summary
- As of February 7, 2025, LGND quarterly stockholders equity is $841.18 million, with the most recent change of +$65.98 million (+8.51%) on September 30, 2024.
- Over the past year, LGND quarterly shareholders equity has increased by +$173.28 million (+25.94%).
- LGND quarterly shareholders equity is now -22.11% below its all-time high of $1.08 billion, reached on March 31, 2019.
Performance
LGND Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LGND Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | +25.9% |
| 3 y3 years | -1.2% | +3.0% |
| 5 y5 years | +25.0% | +3.0% |
LGND Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | +17.3% | at high | +40.8% |
| 5 y | 5-year | -14.6% | +17.3% | at high | +40.8% |
| alltime | all time | -14.6% | +734.8% | -22.1% | +434.9% |
Ligand Pharmaceuticals Incorporated Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $841.18 M(+8.5%) |
| Jun 2024 | - | $775.20 M(-3.9%) |
| Mar 2024 | - | $806.52 M(+15.1%) |
| Dec 2023 | $700.91 M(+17.3%) | $700.91 M(+4.9%) |
| Sep 2023 | - | $667.90 M(+0.5%) |
| Jun 2023 | - | $664.89 M(+2.9%) |
| Mar 2023 | - | $646.32 M(+8.2%) |
| Dec 2022 | $597.49 M(-27.2%) | $597.49 M(-26.8%) |
| Sep 2022 | - | $816.30 M(+1.7%) |
| Jun 2022 | - | $802.37 M(+1.2%) |
| Mar 2022 | - | $793.19 M(-3.4%) |
| Dec 2021 | $821.16 M(+15.7%) | $821.16 M(+1.1%) |
| Sep 2021 | - | $812.07 M(+3.2%) |
| Jun 2021 | - | $786.52 M(+5.5%) |
| Mar 2021 | - | $745.84 M(+5.1%) |
| Dec 2020 | $709.52 M(-7.5%) | $709.52 M(+1.7%) |
| Sep 2020 | - | $697.82 M(+0.4%) |
| Jun 2020 | - | $695.00 M(+5.0%) |
| Mar 2020 | - | $661.90 M(-13.7%) |
| Dec 2019 | $767.23 M(+36.8%) | $767.23 M(-9.8%) |
| Sep 2019 | - | $850.58 M(-18.3%) |
| Jun 2019 | - | $1.04 B(-3.6%) |
| Mar 2019 | - | $1.08 B(+92.5%) |
| Dec 2018 | $560.91 M(+34.0%) | $560.91 M(-19.8%) |
| Sep 2018 | - | $699.52 M(+12.9%) |
| Jun 2018 | - | $619.81 M(+24.7%) |
| Mar 2018 | - | $497.18 M(+18.8%) |
| Dec 2017 | $418.65 M(+12.9%) | $418.65 M(-1.4%) |
| Sep 2017 | - | $424.76 M(+3.8%) |
| Jun 2017 | - | $409.41 M(+2.7%) |
| Mar 2017 | - | $398.78 M(+7.5%) |
| Dec 2016 | $370.85 M(+33.9%) | $370.85 M(+0.1%) |
| Sep 2016 | - | $370.39 M(-5.5%) |
| Jun 2016 | - | $391.92 M(-0.0%) |
| Mar 2016 | - | $392.08 M(+41.6%) |
| Dec 2015 | $276.91 M(+952.2%) | $276.91 M(-5.2%) |
| Sep 2015 | - | $292.18 M(+323.1%) |
| Jun 2015 | - | $69.05 M(+96.5%) |
| Mar 2015 | - | $35.15 M(+33.6%) |
| Dec 2014 | $26.32 M(-47.0%) | $26.32 M(-40.7%) |
| Sep 2014 | - | $44.37 M(-30.9%) |
| Jun 2014 | - | $64.17 M(-1.3%) |
| Mar 2014 | - | $65.00 M(+31.0%) |
| Dec 2013 | $49.61 M(+87.3%) | $49.61 M(+10.7%) |
| Sep 2013 | - | $44.81 M(+14.1%) |
| Jun 2013 | - | $39.27 M(+28.3%) |
| Mar 2013 | - | $30.60 M(+15.5%) |
| Dec 2012 | $26.48 M(+223.6%) | $26.48 M(+24.7%) |
| Sep 2012 | - | $21.23 M(+15.1%) |
| Jun 2012 | - | $18.45 M(-4.1%) |
| Mar 2012 | - | $19.24 M(+135.1%) |
| Dec 2011 | $8.19 M(-268.8%) | $8.19 M(+245.8%) |
| Sep 2011 | - | $2.37 M(-55.6%) |
| Jun 2011 | - | $5.33 M(+6.3%) |
| Mar 2011 | - | $5.01 M(-203.3%) |
| Dec 2010 | -$4.85 M(-229.5%) | -$4.85 M(-48.6%) |
| Sep 2010 | - | -$9.44 M(-455.4%) |
| Jun 2010 | - | $2.66 M(+23.8%) |
| Mar 2010 | - | $2.15 M(-42.7%) |
| Dec 2009 | $3.74 M | $3.74 M(-139.4%) |
| Sep 2009 | - | -$9.50 M(-22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -$12.26 M(-16.6%) |
| Mar 2009 | - | -$14.70 M(+41.8%) |
| Dec 2008 | -$10.37 M(-135.6%) | -$10.37 M(-630.5%) |
| Sep 2008 | - | $1.95 M(-89.7%) |
| Jun 2008 | - | $19.02 M(-22.5%) |
| Mar 2008 | - | $24.53 M(-15.7%) |
| Dec 2007 | $29.11 M(+6.4%) | $29.11 M(+10.7%) |
| Sep 2007 | - | $26.29 M(-23.2%) |
| Jun 2007 | - | $34.23 M(-40.4%) |
| Mar 2007 | - | $57.40 M(+109.9%) |
| Dec 2006 | $27.35 M(-124.8%) | $27.35 M(-110.9%) |
| Sep 2006 | - | -$251.19 M(+5.3%) |
| Jun 2006 | - | -$238.50 M(+6.3%) |
| Mar 2006 | - | -$224.36 M(+103.2%) |
| Dec 2005 | -$110.42 M(+46.6%) | -$110.42 M(+1.8%) |
| Sep 2005 | - | -$108.41 M(+5.9%) |
| Jun 2005 | - | -$102.39 M(+9.0%) |
| Mar 2005 | - | -$93.96 M(+24.7%) |
| Dec 2004 | -$75.32 M(+100.6%) | -$75.32 M(-283.9%) |
| Sep 2004 | - | $40.96 M(-14.7%) |
| Jun 2004 | - | $48.00 M(-20.5%) |
| Mar 2004 | - | $60.37 M(-260.8%) |
| Dec 2003 | -$37.55 M(-150.7%) | -$37.55 M(-160.0%) |
| Sep 2003 | - | $62.60 M(+131.3%) |
| Jun 2003 | - | $27.06 M(-28.8%) |
| Mar 2003 | - | $38.02 M(-48.6%) |
| Dec 2002 | $74.02 M(-227.9%) | $74.02 M(-8.2%) |
| Sep 2002 | - | $80.67 M(-7.3%) |
| Jun 2002 | - | $87.01 M(+180.5%) |
| Mar 2002 | - | $31.02 M(-153.6%) |
| Dec 2001 | -$57.88 M(+5.0%) | -$57.88 M(+10.9%) |
| Sep 2001 | - | -$52.17 M(+14.3%) |
| Jun 2001 | - | -$45.63 M(+19.4%) |
| Mar 2001 | - | -$38.23 M(-30.7%) |
| Dec 2000 | -$55.13 M(+115.3%) | -$55.13 M(+81.7%) |
| Sep 2000 | - | -$30.34 M(+80.5%) |
| Jun 2000 | - | -$16.81 M(+33.0%) |
| Mar 2000 | - | -$12.64 M(-50.6%) |
| Dec 1999 | -$25.60 M(+124.6%) | -$25.60 M(-43.1%) |
| Sep 1999 | - | -$45.00 M(+48.5%) |
| Jun 1999 | - | -$30.30 M(+91.8%) |
| Mar 1999 | - | -$15.80 M(+38.6%) |
| Dec 1998 | -$11.40 M(-133.2%) | -$11.40 M(-256.2%) |
| Sep 1998 | - | $7.30 M(-46.7%) |
| Jun 1998 | - | $13.70 M(-39.9%) |
| Mar 1998 | - | $22.80 M(-33.5%) |
| Dec 1997 | $34.30 M(-0.6%) | $34.30 M(+113.0%) |
| Sep 1997 | - | $16.10 M(-30.3%) |
| Jun 1997 | - | $23.10 M(-28.3%) |
| Mar 1997 | - | $32.20 M(-6.7%) |
| Dec 1996 | $34.50 M(+22.8%) | $34.50 M(+305.9%) |
| Sep 1996 | - | $8.50 M(-33.1%) |
| Jun 1996 | - | $12.70 M(-42.8%) |
| Mar 1996 | - | $22.20 M(-21.0%) |
| Dec 1995 | $28.10 M(+6.8%) | $28.10 M(-14.1%) |
| Sep 1995 | - | $32.70 M(+25.3%) |
| Mar 1995 | - | $26.10 M(-0.8%) |
| Dec 1994 | $26.30 M | $26.30 M(-19.6%) |
| Sep 1994 | - | $32.70 M(+14.7%) |
| Jun 1994 | - | $28.50 M(-20.6%) |
| Mar 1994 | - | $35.90 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
- What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
The current annual shareholders equity of LGND is $700.91 M
What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual stockholders equity is $821.16 M
What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
Over the past year, LGND annual stockholders equity has changed by +$103.43 M (+17.31%)
What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
The current quarterly shareholders equity of LGND is $841.18 M
What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly stockholders equity is $1.08 B
What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
Over the past year, LGND quarterly stockholders equity has changed by +$173.28 M (+25.94%)